IA
JSPRW icon

IFP Advisors’s Japer Therapeutics Warrants JSPRW Stock Holding History

IFP Advisors’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
50
– – ﹤0.01% 5125
2026
Q1 		$1 Hold
50
– – ﹤0.01% 5012
2025
Q4 		$2 Hold
50
– – ﹤0.01% 4871
2025
Q3 		$4 Hold
50
– – ﹤0.01% 4810
2025
Q2 		$4 Buy
+50
New +$5 ﹤0.01% 4888

IFP Advisors's JSPRW Position: Q2 2026 in Review

IFP Advisors held its Japer Therapeutics Warrants (JSPRW) position steady in Q2 2026 at 50 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5125.

IFP Advisors first reported a position in JSPRW in Q2 2025 and has held it in 5 quarters since. The position peaked at $4 in Q3 2025. 1 fund tracked by Wall St. Rank holds JSPRW as of Q2 2026.

  • IFP Advisors held 50 shares of Japer Therapeutics Warrants worth $1 as of Q2 2026.
  • IFP Advisors left its Japer Therapeutics Warrants share count unchanged in Q2 2026.
  • Japer Therapeutics Warrants made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5125 holding.
  • IFP Advisors first reported a position in Japer Therapeutics Warrants in Q2 2025 and has held it in 5 quarters since.
  • IFP Advisors's Japer Therapeutics Warrants position peaked at $4 in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.